These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17363485)

  • 1. A novel class of pyranocoumarin anti-androgen receptor signaling compounds.
    Guo J; Jiang C; Wang Z; Lee HJ; Hu H; Malewicz B; Lee HJ; Lee JH; Baek NI; Jeong JH; Kim DK; Kang KS; Kim SH; Lu J
    Mol Cancer Ther; 2007 Mar; 6(3):907-17. PubMed ID: 17363485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents.
    Lu J; Kim SH; Jiang C; Lee H; Guo J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1365-72. PubMed ID: 17723170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.
    Zhang Y; Shaik AA; Xing C; Chai Y; Li L; Zhang J; Zhang W; Kim SH; Lü J; Jiang C
    Invest New Drugs; 2012 Oct; 30(5):1820-9. PubMed ID: 21870073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
    Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
    Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.
    Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J
    Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
    Jiang C; Guo J; Wang Z; Xiao B; Lee HJ; Lee EO; Kim SH; Lu J
    Breast Cancer Res; 2007; 9(6):R77. PubMed ID: 17986353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
    Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
    Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
    Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
    Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-androgen receptor signaling and prostate cancer inhibitory effects of sucrose- and benzophenone-compounds.
    Wang Z; Lee HJ; Wang L; Jiang C; Baek NI; Kim SH; Lü J
    Pharm Res; 2009 May; 26(5):1140-8. PubMed ID: 19266268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD; Gleave ME
    Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.
    Zhang Y; Kim KH; Zhang W; Guo Y; Kim SH; Lü J
    Int J Cancer; 2012 Jan; 130(1):200-12. PubMed ID: 21328348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.
    Kim SH; Singh SV
    Mol Cancer Ther; 2009 Jul; 8(7):1946-54. PubMed ID: 19584240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
    Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R
    Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
    Bhattacharyya RS; Krishnan AV; Swami S; Feldman D
    Mol Cancer Ther; 2006 Jun; 5(6):1539-49. PubMed ID: 16818513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
    Kawata H; Arai S; Nakagawa T; Ishikura N; Nishimoto A; Yoshino H; Shiraishi T; Tachibana K; Nakamura R; Sato H
    Prostate; 2011 Sep; 71(12):1344-56. PubMed ID: 21308717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
    Kim J; Park H; Im JY; Choi WS; Kim HS
    Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.